Safety and Efficacy Study of Subcutaneous Belimumab and Intravenous Rituximab Co-administration in Subjects With Primary Sjogren's Syndrome
Clinical trial NCT02631538 · COMPLETED
Trial details
- NCT number
- NCT02631538
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-02-17
- Primary completion
- 2020-06-23
- Enrollment
- 86
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.